Fundraising Fox
/Companies
Sign in

Combined Therapeutics

Cambridge, US · Founded 2016 · Delaware corporation

Find your way into Combined Therapeutics

Sign up to see every warm intro you have to Combined Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Combined Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Combined Therapeutics Inc. (CTx) is a privately held biotechnology company developing mRNA vaccines and therapeutics using a proprietary multi-organ protection technology for tissue-specific mRNA expression. Its initial focus is on vaccines and vaccine adjuvants for infectious diseases and oncology.

AI & Machine LearningBiotechHealthtech

Founders & leadership

Combined Therapeutics was founded in 2016 by Dan Anderson.

DADan Anderson
Dan AndersonCo-founderCo-founder of Combined Therapeutics, a biotechnology company developing mRNA vaccines and therapeutics. Anderson has held operations roles with increasing responsibility across multiple organizations.
JR
Justine RyanNamed on SEC filing
RM
Romain MicolPresident and co-founder CEO
PMPierre Matussiere
Pierre MatussiereNon Executive Director
RL
Robert LangerCo-founder

Reported raises · per SEC filings

Form D private placements

$250K disclosed across 1 round · 2017

▶$250KraisedDec 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel AndersonDirector
  • Justine RyanDirector
  • Romain MicolExecutive Officer, Director
  • Pierre MatussiereDirector
  • Robert LangerDirector
Offering amount
$2M
Amount sold
$250K
First sale
Nov 2017
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

SoluSolu Therapeutics is a clinical-stage biotech developing a class of antibody therapeutics that link bifunctional small molecules to proprietary effector antibodies (its CyTAC and TicTAC platforms) to reach cell surface targets like GPCRs and ion channels. Its pipeline targets oncology, immunology and inflammation, and pain, with a lead program in Phase 1 trials for chronic myelomonocytic leukemia.
Transcode TherapeuticsTransCode Therapeutics is an RNA-focused drug developer building oncology therapeutic candidates and diagnostics, using its TTX delivery technology across immunotherapy, gene editing, radiotherapy, and cancer vaccines. Its pipeline targets cancers such as pancreatic cancer through RNAi, RIG-I agonism, CRISPR, radioisotope delivery, and mRNA-based vaccines.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Combined Therapeutics.

Frequently asked questions

What does Combined Therapeutics do?
Combined Therapeutics Inc. (CTx) is a privately held biotechnology company developing mRNA vaccines and therapeutics using a proprietary multi-organ protection technology for tissue-specific mRNA expression. Its initial focus is on vaccines and vaccine adjuvants for infectious diseases and oncology.
Who founded Combined Therapeutics?
Combined Therapeutics was founded by Dan Anderson in 2016.
How much funding has Combined Therapeutics raised?
Combined Therapeutics has disclosed $250K raised across 1 round.
Where is Combined Therapeutics headquartered?
Combined Therapeutics is headquartered in Cambridge, US.